This study detected the above tumor markers and found that patients with colorectal cancer had higher CEA, CA19-9, CA125 levels than patients with benign colorectal lesions, and CEA, CA19-9, CA125 increase were more evident in high-density group. The gene discussed is CEACAM5; the disease is colorectal cancer.